The liver cancer therapeutics industry grows at 16.5% CAGR to US$13.16 billion by 2033, propelled by generics and screening programs. Learn about Europe's 34.5% share, cholangiocarcinoma applications, and global shifts toward accessible, outpatient oncology treatments. https://finance.yahoo.com/news/liver-cancer-therapeutics-market-size-140100776.html